chrisvoncsefalvay/vaers-outcomes huggingface dataset:
chest pain over left side of the sternum when touched the area is very painful...pericarditis; Vertigo symptom/my head was spinning so badly; started to throw up profusely; dizziness was so bad; first time I am experiencing a reaction; about to pass out; This spontaneous case was reported by a dentist and describes the occurrence of PERICARDITIS (developed chest pain over left side of the sternum when touched the area is very painful, so I strongly believe its pericarditis) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMINS NOS for an unknown indication.    On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jun-2021, the patient experienced DIZZINESS (The dizziness was so bad, I thought that, "I am going to die"), VACCINATION COMPLICATION (this was the first time I am experiencing a reaction ) and PRESYNCOPE (about to pass out). On 06-Jun-2021 at 2:00 AM, the patient experienced VERTIGO (Vertigo symptom/my head was spinning so badly) and VOMITING (started to throw up profusely). On 06-Jun-2021 at 4:00 PM, the patient experienced PERICARDITIS (developed chest pain over left side of the sternum when touched the area is very painful, so I strongly believe its pericarditis) (seriousness criterion medically significant). On an unknown date, the patient experienced ILLNESS (very sick). The patient was treated with IBUPROFEN for Pericarditis, at a dose of 1 dosage form, unknown. On 06-Jun-2021, VERTIGO (Vertigo symptom/my head was spinning so badly), DIZZINESS (The dizziness was so bad, I thought that, "I am going to die"), PRESYNCOPE (about to pass out) and VOMITING (started to throw up profusely) had resolved. At the time of the report, PERICARDITIS (developed chest pain over left side of the sternum when touched the area is very painful, so I strongly believe its pericarditis) had not resolved and ILLNESS (very sick) outcome was unknown.     The outcome of the event of VACCINATION COMPLICATION (this was the first time I am experiencing a reaction ) was resolved.   mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The reporter noted he never had any adverse reaction after taking any medications before and this was the first time he was experiencing a reaction. He reported to be a healthy person before and now after receiving the Moderna vaccine, he is very sick. The reporter stated that he "will not take the 2nd dose of Moderna vaccine."; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 72-year-old female patient who received SHINGRIX for prophylaxis. On 17th November 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: In 2018, the patient experienced arm pain. The reporter did not consent to follow-up. This case has been linked with case US2018230492 (husband's case), reported by the same reporter and for tolerance to next dose, refer case US2018230489.
Pneumonia; Initial information received on 15-Feb-2021 regarding an unsolicited valid serious case received from a consumer or non-healthcare professional (reference number: US-SA-SAC20210218000391, other: SAC20210218000391).  This case involves a patient (gender and age not reported) who experienced pneumonia, after receiving INFLUENZA VACCINE.  Medical history, past medical treatment, past vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed serious pneumonia (unknown latency) following the administration of INFLUENZA VACCINE.   This event was assessed as medically significant.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for the event.  Information on the batch number was requested.; Sender's Comments: This case concerns a patient (gender and age not reported) who experienced pneumonia after vaccination with INFLUENZA VACCINE. The time to onset is unknown. Further information regarding medical history, concurrent condition during vaccination, laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
HEADACHE; EXTREME TIRED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included no smoking, and non alcohol user, and other pre-existing medical conditions included the patient had no known allergies and not any drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 18-MAR-2021 at right arm for prophylactic vaccination. No concomitant medications were reported. On 18-MAR-2021, the subject experienced headache. On 18-MAR-2021, the subject experienced extreme tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, and extreme tired. This report was non-serious.
Pain at injection site, numbness and tingling sensation in arm, headaches, fatigue, dizziness, temp of 100, achiness in legs and neck, knot appeared under armpit.
pt recv vax 19OCT95 & 27DEC95 a varicella antibody titer was neg;no further details were provided;
Swelling in site area about 4"-5" in size with vesicles; no pustules.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 11-NOV-2014 the patient was vaccinated with an expired dose of PNEUMOVAX 23 (dose, route not reported, lot # J004080, expiration date 22-AUG-2014). Concomitant medications were not provided. No adverse effects were reported. Additional information has been requested.
some doses that might have been administered up to 50 days after being in the refrigerator; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (some doses that might have been administered up to 50 days after being in the refrigerator) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (some doses that might have been administered up to 50 days after being in the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (some doses that might have been administered up to 50 days after being in the refrigerator) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug details were reported.  No treatment details were reported.
This is a spontaneous report from a contactable pharmacist via a Pfizer sales representative. This pharmacist reported similar events for two female patients (one 70 and one 90-year-old). This is the 1st of two reports. An elderly female patient received PREVNAR 13; (lot number and expiration date were unknown), via an unspecified route of administration on an unspecified date at a single dose for immunization, and FLUZONE; (reported as HD flu (pending clarification)), via an unspecified route of administration on an unspecified date at an unspecified dose for immunization. The patient's medical history and concomitant medications were not reported. The pharmacist reported that the patients received both HD flu vaccine and pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein), and both experienced significant systemic reactions. This patient was out sick for a few days. The outcome of the event sick was unknown. Information on the batch/lot number has been requested. Sender's Comments: Linked Report(s): US-PFIZER INC-2018414481 same reporter/drug, same event and different patient.
pt recvd vax & 1wk post vax exp excess thirst,blurred vision,chills,sweats & was tired;sx have not subsided;
I started having severe muscle spasms in my lower back pain to the point where I was unable to get off the couch. I could hardly walk. This lasted for about a month getting better on a week by week basis, I went to the chiropractor and he did not see anything wrong. The chiropractic still did an adjustment and that helped. It took about a full month to get better. I also had an xray at a different providers office to see if my hip was causing the issue.
arm soreness; receive vaccine by accident; he was scheduled for a different vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (receive vaccine by accident) and WRONG PRODUCT ADMINISTERED (he was scheduled for a different vaccine) in a 12-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (receive vaccine by accident) and WRONG PRODUCT ADMINISTERED (he was scheduled for a different vaccine). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm soreness). On 12-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (receive vaccine by accident) and WRONG PRODUCT ADMINISTERED (he was scheduled for a different vaccine) had resolved. At the time of the report, PAIN IN EXTREMITY (arm soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.  No treatment medication information was given.
A couple days after getting the vaccine, patient got fever, redness and swelling on her arm.  Patient said that she was later treated in the hospital with antibiotic. She was diagnosed with infection on her arm down to the elbow. It's probably because of her immune-suppressant medication for her Rheumatoid arthritis.
This spontaneous report was received from a licensed vocational nurse referring a patient of unknown age and gender. Information about concurrent conditions, medical history, concomitant medications and drug reactions or allergies was not provided. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (lot # N003993, expiration date 20-OCT-2018, dose and route of administration were not reported), for prophylaxis. Subsequently, the nurse noted that, at the time of reporting, the patient was experiencing injection site reaction with red, hot and hard lump at the injection site, which was most likely cellulitis. The nurse also noted that the patient was experiencing pain (reported as aches and pains). No further information was provided. The outcome of administration site cellulitis, injection site erythema, injection site induration, injection site warmth and pain was unknown. The causal relationship between the events and the therapy with PNEUMOVAX 23 was not reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1703USA012535: US-009507513-1703USA011244.
Patchy loss of facial hair after 1st shot Lot #FAV020, pain in elbows, feet and knees within the last 3 months (2/23/00) Lot #FAV024, daily extreme fatigue within the last 3 months, Lot #FAV024. Follow up 10/19/2000: "Patient did not recover from adverse events.  Loss of facial hair, lack of energy (chronic). Patient received further shots...EVENT: Increased facial hair loss with each injection."  Follow up 03/27/2001: "I am responding to numerous requestes for access to my medical records.  In my opinion access to these records is not warranted and is therefore denied.  The description of adverse reactions was described in my initial report, and the treatment for loss of my facial hair was hormone shots in the effected areas.  I only subjected myself to one of these painful treatments, since I am required by the Air Force to remain current on the vaccination, and I believe to be the cause of my problem.  I firmly believe that any adverse reaction to the vaccine, like the existence of "Gulf War Illness", will be denied.  Like Agent Orange, if there is ever any evidence of health problems from the vaccine it will be many years before anyone will see any help, so I don't see any point in continuing to pursue this matter.  Thank you for your concern in this matter."
12 hours after injection.  Fever of 103 that lasted 18 hours.  Chills that lasted 12 hours.  Headache that lasted four days not resolved with treatment with Tylenol and exceeding.  Intense Axillary pain on arm shot was given for three days.  Back pain on the side shot was given for two days.
Pain at injection site, immediate dizziness, lightheadedness, feeling like head heavy and like someone slamming it, forgetfulness. Extremities felt heavy, like I'd been drugged. Pharmacy people took turns staying with me in the waiting area for an hour until I could walk out of the store and drive the five-minute drive home. Slept all afternoon. Felt nausea in evening, which persisted the next day along with dizziness and need to sleep. This is second day and feeling better by evening, but not fully recovered from lightheadedness. Called my doctor and reported adverse effects.
approximately 10 hours into shot experienced chills, headache fatigue and sore eyes.  My eyes looked pink like I was sick, glassy sore.Took tylenol extra strength every 6 hours to manage the chills they were the worse.  No fever or nausea.  By Sunday 1/24/2021 approximately 10 p.m. the only symptom left was fatigue and sore eyes.  Monday 1/25/21 still tired no chills no aches eyes still puffy red.  Tuesday 1/26/21 better not as tired, eyes not as red or itchy.
EE reports he received pfizer vaccine on 1/21/21.  He noted extreme fatigue on 1/22/21 and today 1/23/21 noted an inability to form words and talk while on the phone, dizzy, tongue is half numb, and notes sweating.   EE advised to f/u with ER for assessment.  Consult with Dr.  e-mail was sent alerting her to this reaction.  MAJ follow up on 1/26:  ED record reviewed.  EE had vaccine injected on 1/21 and experienced chills and nausea on 1/22.  On 1/23 he had 1-2 minutes of aphasia and R jaw numbness.  ED evaluation that afternoon revealed a well-appearing adult with normal vital signs and neurologic exam.  Assessment by ED physician was that this was not a stroke or transient ischemic attack but might be a vaccine-related adverse event.  The ee was referred for follow-up with his PCP, Dr. , who can be emailed if further follow up information is needed.  I suspect the ee became dehydrated from vaccine-related nausea and that this was the cause of his transient neurologic symptoms.
Pt initially admitted to the covid medical floor with respiratory failure. She was on nasal cannula which rapidly progressed to high flow cannula. Pt was struggling with anxiety which did contribute to her increasing oxygen requirements and repetitive hypoxic events. Decision was made to transfer her to the ICU on 11/2/2021 given that she was unable to come off NIV.  Once on ventilator, Pt required maximum ventilator settings and eventually even nitric oxide. Despite all interventions, Pt rapidly deteriorated on 11/9/2021. Husband and grandson arrived to bedside. Pt went into PEA, CPR was performed. She was able to regain a pulse for a few minutes then again went pulseless. CPR was performed until husband requested all efforts to be terminated. Pt was pronounced deceased @ 1135 on 11/9/2021
Patient given expired medication, manufacturer contacted; vaccine maintained the activity necessary to protect against Covid-19 virus at time of administration.
Developed Bell's Palsy.  Experienced facial muscle weakness and facial paralysis on the left side. Mouth was twisted and left eye blinked very slowly.  Also experienced facial twitching difficulty swallowing  on the left side.
Mouth swelling Hives on arms and face (forehead and near eyes) Itching mainly on arms , ears ,  along back hairline
chills day 1 and 2; tiredness; headache; muscle pain; joint pain; feeling unwell; dizziness; weakness; sleeplessness; sinus unable to drain, feels like sinus infection but no fever; This is a spontaneous report from a contactable health care professional (patient).  A 62-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL1283) in the hospital, via intramuscular route of adminsitration on 08Jan2021 at 15:00 at a single dose on the left arm for COVID-19 immunization.  Medical history included Diabetes, High blood pressure, Osteoporosis, Hyperlipidemia, GERD, Diverticulosis and allergies to soaps, shampoos and lotions all from an unknown date and unknown if ongoing. Concomitant medication included metformin (manufacturer unknown), losartan (manufacturer unknown), ezetimibe (manufacturer unknown), esomeprazole (manufacturer unknown), dulaglutide (TRULICITY) , hctz (manufacturer unknown), denosumab (PROLIA), Alive multi vitamin (as reported), vitamin d3 (manufacturer unknown), ascorbic acid, colecalciferol, copper gluconate, cyanocobalamin, durapatite, folic acid, glucosamine hydrochloride, magnesium oxide, manganese sulfate, phytomenadione, sodium borate decahydrate, zinc amino acid chelate (BONE UP), alpha-amylase swine pancreas, cellulase, lipase, protease nos (DIGESTIVE ENZYME) and curcuma longa rhizome (TURMERIC CURCUMIN [CURCUMA LONGA RHIZOME]). The patient had no other vaccines in four weeks. The patient did not have COVID-19 prior to vaccination. It was reported that the patient had chills day 1 and 2, tiredness, headache, muscle pain, joint pain, feeling unwell, dizziness, weakness, sleeplessness and sinus unable to drain, feels like sinus infection but no fever all on 08Jan2021 at 19:00. The patient took Advil, Mucinex and Walphed as treatment for the events. The outcome of the events was not recovered. The patient has not been tested for COVID-19 post vaccination.
Patient has shoulder pain after the vaccine. Patient stated shot was painful immediately after receiving. Patient had difficulty sleeping that night, it is waking him up at night. Patient tried acetaminophen with no relief. Patient cannot lift arm without pain. Patient stated the vaccine was given too high. Patient has had pain in the shoulder since receiving the vaccine.
hypodermic needle hit something that caused a repulsive reaction. considering guidelines, and experience with primary covid vaccine on 8/30/21 which caused diminishing shoulder pain over 3 days, I thought this was going to cease at sometime.  The pain persisted and became worse. I continued to exercise my right shoulder muscle in an effort to eliminate the painful discomfort.  The pain is such that it hurts to move my arm from the shoulder area: ie, not elbow, but up, out, back, etc. After many weeks, I went to clinic to inquire if this condition has been experienced before and what to do about it. I was instructed to file this report and talk to a physician.
Patient experiences pain, numbness, tingling in left arm at injection site and all the way down to the hand. Also has discoloration of hand at times (turns blue)
Redness, swelling, ecchymosis 9x12 cm.  Patient was seen by an MD. Local reaction only, resolved with anti-histamine in 23 days.
Vaccine leaked out of syringe; Vaccine leaked out of syringe; Patient did not get any of the dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of DEVICE CONNECTION ISSUE (Vaccine leaked out of syringe), UNDERDOSE (Vaccine leaked out of syringe) and ACCIDENTAL UNDERDOSE (Patient did not get any of the dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced DEVICE CONNECTION ISSUE (Vaccine leaked out of syringe), UNDERDOSE (Vaccine leaked out of syringe) and ACCIDENTAL UNDERDOSE (Patient did not get any of the dose). On 25-May-2021, DEVICE CONNECTION ISSUE (Vaccine leaked out of syringe), UNDERDOSE (Vaccine leaked out of syringe) and ACCIDENTAL UNDERDOSE (Patient did not get any of the dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant Medications were not provided by the reporter. Treatment Medications were not provided by the reporter
mom reported 28MAY that daughter had rash that covered face, enck arms & legs, some on chest the next day p/vax but had cleared x/for legs;4JUNmom reported daughter still has rash on legs;legs swollen & tight c/o pain;
This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (feels dizzy, like she has vertigo), VERTIGO (felt llike she had vertigo), VACCINATION SITE WARMTH (red and hot at injection site), RASH (rash all over her) and VACCINATION SITE RASH (rash all over arm) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939909) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 17-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (feels dizzy, like she has vertigo), VERTIGO (felt llike she had vertigo), VACCINATION SITE WARMTH (red and hot at injection site), RASH (rash all over her), VACCINATION SITE RASH (rash all over arm), VACCINATION SITE ERYTHEMA (red and hot at injection site) and VACCINATION SITE SWELLING (injection site swollen up like a golf ball). At the time of the report, DIZZINESS (feels dizzy, like she has vertigo), VERTIGO (felt llike she had vertigo), VACCINATION SITE WARMTH (red and hot at injection site), RASH (rash all over her), VACCINATION SITE RASH (rash all over arm), VACCINATION SITE ERYTHEMA (red and hot at injection site) and VACCINATION SITE SWELLING (injection site swollen up like a golf ball) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Patient reports she is on no concomitant medication, but sometimes, she takes a water pill. No treatment medications were reported.